• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    InflaRx Receives CHMP Opinion for GOHIBIC® in SARS-CoV-2 ARDS

    GLOBENEWSWIRE

    InflaRx Reports Q3 2024 Financial Results & Business Update

    GLOBENEWSWIRE

    InflaRx Reports Q2 2024 Results And Provides Business Update

    GLOBENEWSWIRE

    InflaRx Announces Initiation of its Commitment Program for GOHIBIC

    GLOBENEWSWIRE

    InflaRx Announces First Patient Dosed in Phase III Trial with Vilobelimab

    GLOBENEWSWIRE

    InflaRxs Marketing Authorization Application (MAA) for Vilobelimab

    GLOBENEWSWIRE

    InflaRx Announces Commercial Launch of Gohibic vilobelimab

    GLOBENEWSWIRE

    InflaRx Receives FDA Emergency Use Authorization for Gohibic

    GLOBENEWSWIRE

    Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.